Polymeric biomaterials derived from phenolic monomers and their medical uses
US-2016376401-A1 · Dec 29, 2016 · US
US11472918B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11472918-B2 |
| Application number | US-202016791133-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 14, 2020 |
| Priority date | Feb 3, 2012 |
| Publication date | Oct 18, 2022 |
| Grant date | Oct 18, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides new classes of phenol compounds, including those derived from tyrosol and analogues, useful as monomers for preparation of biocompatible polymers, and biocompatible polymers prepared from these monomeric phenol compounds, including novel biodegradable and/or bioresorbable polymers. These biocompatible polymers or polymer compositions with enhanced bioresorbabilty and processibility are useful in a variety of medical applications, such as in medical devices and controlled-release therapeutic formulations. The invention also provides methods for preparing these monomeric phenol compounds and biocompatible polymers.
Opening claim text (preview).
What is claimed is: 1. A biocompatible polymer, comprising a recurring unit of Formula XVIII: wherein: (a) A is CH 2 or CH 2 CH 2 , B is a bond, Y is selected from the group consisting of (CH 2 ) 2 , (CH 2 ) 3 , CH 2 OCH 2 , (CH 2 ) 4 , CH 2 CH═CHCH 2 , (CH 2 ) 5 , (CH 2 ) 6 , and (CH 2 ) 10 ; Or (b) A is CH 2 CH 2 , B is selected from the group consisting of —O—CO—CH 2 CH 2 , —O—CO—CH 2 CH 2 CH 2 , and —O—CO—CH 2 OCH 2 and bonded to A via oxygen, Y is selected from the group consisting of (CH 2 ) 2 , (CH 2 ) 3 , CH 2 OCH 2 , (CH 2 ) 4 , CH 2 CH═CHCH 2 , (CH 2 ) 5 , (CH 2 ) 6 , and (CH 2 ) 10 . 2. The polymer of claim 1 , wherein the repeating unit is represented by Formula XVIII-a. 3. The polymer of claim 2 , wherein A is CH 2 , Y is selected from the group consisting of (CH 2 ) 2 , (CH 2 ) 3 , CH 2 OCH 2 , (CH 2 ) 4 , CH 2 CH═CHCH 2 , (CH 2 ) 5 , (CH 2 ) 6 , and (CH 2 ) 10 . 4. The polymer of claim 2 , wherein A is or CH 2 CH 2 , Y is selected from the group consisting of (CH 2 ) 2 , (CH 2 ) 3 , CH 2 OCH 2 , (CH 2 ) 4 , CH 2 CH═CHCH 2 , (CH 2 ) 5 , (CH 2 ) 6 , and (CH 2 ) 10 . 5. The polymer of claim 1 , wherein the repeating unit is represented by Formula XVIII-b. 6. The polymer of claim 5 , wherein B is —O—CO—CH 2 CH 2 . 7. The polymer of claim 5 , wherein B is —O—CO—CH 2 CH 2 CH 2 . 8. The polymer of claim 5 , wherein B is —O—CO—CH 2 OCH 2 . 9. A polymer composition comprising a biocompatible polymer of claim 1 .
Esters of carbonic or haloformic acids · CPC title
Polyesters containing oxygen in the form of ether groups (C08G63/42, C08G63/58 take precedence) · CPC title
Compositions for preparing biodegradable polymers · CPC title
Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)} · CPC title
obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.